Cargando…
Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447113/ https://www.ncbi.nlm.nih.gov/pubmed/34533769 http://dx.doi.org/10.1007/s12020-021-02879-8 |
| _version_ | 1784569001882419200 |
|---|---|
| author | Sriphrapradang, Chutintorn |
| author_facet | Sriphrapradang, Chutintorn |
| author_sort | Sriphrapradang, Chutintorn |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8447113 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84471132021-09-17 Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease Sriphrapradang, Chutintorn Endocrine Letter to the Editor Springer US 2021-09-17 2021 /pmc/articles/PMC8447113/ /pubmed/34533769 http://dx.doi.org/10.1007/s12020-021-02879-8 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Sriphrapradang, Chutintorn Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease |
| title | Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease |
| title_full | Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease |
| title_fullStr | Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease |
| title_full_unstemmed | Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease |
| title_short | Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease |
| title_sort | aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored sars-cov-2 vaccine in a patient with graves’ disease |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447113/ https://www.ncbi.nlm.nih.gov/pubmed/34533769 http://dx.doi.org/10.1007/s12020-021-02879-8 |
| work_keys_str_mv | AT sriphrapradangchutintorn aggravationofhyperthyroidismafterheterologousprimeboostimmunizationwithinactivatedandadenovirusvectoredsarscov2vaccineinapatientwithgravesdisease |